OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2023
(2)
2018
(2)
2010
(2)
2008
(2)
2022
(1)
2021
(1)
2016
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Complications of particle embolization of meningiomas: frequency, risk factors, and outcome.
Not available
S-EPMC7964095
|
biostudies-literature
Cite
Late adverse events in coiled ruptured aneurysms with incomplete occlusion at 6-month angiographic follow-up.
Not available
S-EPMC7963999
|
biostudies-literature
Cite
WEB Treatment of Ruptured Intracranial Aneurysms.
Not available
S-EPMC7984684
|
biostudies-literature
Cite
The Woven EndoBridge (WEB) as primary treatment for unruptured intracranial aneurysms.
Not available
S-EPMC6116134
|
biostudies-literature
Cite
Posterior inferior cerebellar artery aneurysms: incidence, clinical presentation, and outcome of endovascular treatment.
Not available
S-EPMC8119094
|
biostudies-literature
Cite
Endovascular treatment of symptomatic intradural vertebral dissecting aneurysms.
Not available
S-EPMC8119076
|
biostudies-literature
Cite
Reconstructive endovascular treatment of fusiform and dissecting basilar trunk aneurysms with flow diverters, stents, and coils.
Not available
S-EPMC7964923
|
biostudies-literature
Cite
Mid-term 3T MRA follow-up of intracranial aneurysms treated with the Woven EndoBridge.
Not available
S-EPMC6259330
|
biostudies-literature
Cite
Microglial Calcium Waves During the Hyperacute Phase of Ischemic Stroke.
Not available
S-EPMC7770090
|
biostudies-literature
Cite
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.
Not available
S-EPMC9931032
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets